osteoarthritis of the hip, osteonecrosis of the femoral head (Ficat IIIB or IV), and developmental dysplasia of the hip
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who require unilateral initial THA surgery due to hip osteoarthritis, joint destruction, aseptic necrosis of the femoral head, femoral neck fracture, etc; (2) Age range from 18 to 80 years old, regardless of gender; (3) Body mass index is 20-35 kg/m2; (4) The preoperative American Society of Anesthesiologists (ASA) anesthesia risk assessment is graded as Grade I-III; (5) Patients who have signed informed consent forms.
Exclusion criteria
Exclusion criteria: (1) Long term use of opioid drugs (daily or almost daily use of opioid drugs for more than 3 months); (2) Alcohol or drug abuse or allergic reactions to any drugs (local anesthetics, etc.) used in this study; (3) Patients with mental illness, language disorders, and inability to complete the Visual Analog Scale (VAS) for pain assessment; (4) Patients with peripheral neuropathy on the surgical side may have moderate to severe joint deformities or stiffness on the surgical side; (5) Individuals with a history of hip trauma or asymmetrical sensation in both hips; (6) Local skin infection, bleeding, etc. at the site of anesthesia puncture; (7) Abnormal coagulation function (PT, APTT exceeding normal values, INR<=1.4), platelet count<80 × 109/L), Patients with possible abnormal platelet function; (8) Surgeons or anesthesiologists believe that patients are not suitable for inclusion; (9) Patients with surgery time greater than 90 minutes.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Dosage of morphine within 24 h after surgery;Dosage of morphine within 24 h after surgery;Postoperative Visual Analogue Scale Score at rest;Postoperative Visual Analogue Scale Score at motion;Times of sleep interruption due to pain on the night of surgery;Postoperative quadriceps strength;Time until the first walkout of bed after surgery;Time to hospital discharge;postoperative adverse events; | — |
Primary
| Measure | Time frame |
|---|---|
| quality of recovery-15 score; | — |
Countries
China
Contacts
West China Hospital, Sichuan University